DeepMind released Google Antigravity on October 15, 2026, saying it streamlines the search for antimicrobial peptides by integrating data from multiple sources. It is the company's first major software update since its initial release of the Antigravity platform.
DeepMind reported that the platform uses ProtNLM, a model trained to predict biological function from amino acid sequences, and targets the discovery of novel antimicrobial peptides. Availability begins with a public beta, initially for researchers in the life sciences.
"Antigravity provides an agentic science workbench that empowers biologists to discover, structurally evaluate, and prioritize promising targets quickly," said Pengfei Tian, a researcher at DeepMind. This platform compresses what used to be a fragmented search over multiple databases into a single session.
The announcement follows growing concerns over antimicrobial resistance, which could lead to 10 million annual deaths by 2050. DeepMind said the platform helps researchers scan through millions of previously uncharacterized proteins in the UniProt database.
DeepMind did not say how many peptides will be validated through wet-lab testing, and noted that the system still requires experimental validation to confirm its findings. This candidate - along with several others discovered through the same pipeline - are now in wet-lab validation, where experimental results will provide the ultimate test of the agent's analysis.
Source: deepmind
